← Open Payments lookup

INNA STRESZ: Open Payments

NPI 1033847546 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,294 in 136 payments from 40 companies in 2025. Trend: 2023 $108 · 2024 $663 · 2025 $3,294

Food & beverage: $3,016Education: $278
CompanyPaymentsAmount
Janssen Biotech, Inc.18$346
Incyte Corporation9$260
SOBI, INC12$251
Merck Sharp & Dohme LLC9$198
Exelixis Inc.5$184
Lilly USA, LLC11$156
AstraZeneca Pharmaceuticals LP7$144
BIOTRONIK NRO, Inc.1$125
Bayer Healthcare Pharmaceuticals Inc.5$120
Takeda Pharmaceuticals U.S.A., Inc.3$114

Products named: RYBREVANT, KEYTRUDA, VERZENIO, Prospera, Doptelet, IMFINZI, JAKAFI, CABOMETYX.

Industry payments across NV — which companies pay providers there.